Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
DERM Journey Medical
3.860
-0.050-1.28%
Post Mkt Price
3.86000.00%
YOY
Do not show
Hide blank lines
(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31
Total revenue
19.64% 18.29M 117.33% 23.3M 41.78% 63.13M 27.65% 17.52M
Operating revenue
19.28% 18.24M 94.01% 20.8M 41.22% 63.1M 27.7% 17.52M
Cost of revenue
1.99% 7.63M 109.9% 8.2M 119.84% 32.08M 122.49% 9.53M
Gross profit
36.57% 10.66M 121.6% 15.09M 3.72% 31.05M -15.36% 7.99M
Operating expense
-17.47% 17.8M 156.68% 15.98M 155.32% 56.39M 193.14% 17.05M
Selling and administrative expenses
94.88% 15.19M 136.35% 14.72M 80.35% 39.83M 158.89% 15.06M
Research and development costs
-81.06% 2.61M -- 1.27M -- 16.56M -- 1.99M
Operating profit
48.11% -7.14M -251.79% -888K -422.77% -25.34M -349.78% -9.06M
Net non-operating interest income expense
66.47% -450K -74.66% -386K -907.45% -7.03M -1888.35% -4.1M
Non-operating interest income
-- 4K -- 3K -- 2K -- 0
Non-operating interest expense
-66.17% 454K 64.71% 364K 907.74% 7.03M 1888.35% 4.1M
Total other finance cost
-- -- -- 25K -- -- -- --
Other net income (expense)
-9.99M -263K
Gain on sale of security
-- -- -- -- -- -447K -- -263K
Special income (charges)
-- -- -- -- -- -9.54M -- 0
-Less:Other special charges
-- -- -- -- -- 9.54M -- --
Income before tax
50.34% -7.59M -450% -1.27M -692.2% -42.36M -492.28% -13.42M
Income tax
98.13% -64K 8.33% 104K -12.62% 1.63M 807.95% 8.34M
Net income
36.55% -7.53M -614.18% -1.38M -932.75% -43.99M -969.34% -21.75M
Net income continuous Operations
36.55% -7.53M -614.18% -1.38M -932.75% -43.99M -969.34% -21.75M
Minority interest income
Net income attributable to the parent company
36.55% -7.53M -614.18% -1.38M -932.75% -43.99M -969.34% -21.75M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
36.55% -7.53M -614.18% -1.38M -932.75% -43.99M -969.34% -21.75M
Basic earnings per share
40.44% -0.43 -590.8% -0.08 -1445.79% -4.32 -1177.69% -1.64
Diluted earnings per share
40.44% -0.43 -590.8% -0.08 -1445.79% -4.32 -1177.69% -1.64
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
----Unqualified Opinion--

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company’s marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.
CEO: --
Market: NASDAQ
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist
Back to the Top